HeartFlow Names Former J&J Chairman and CEO William C. Weldon Chairman of the Board
REDWOOD CITY, Calif. – June 21, 2017 – HeartFlow, Inc. today announced that William C. Weldon, a board member of the Company since December 2014, has been appointed to chairman. This will enable chairman and chief executive officer John H. Stevens, M.D., to focus on leading HeartFlow into its next stage of growth. Dr. Stevens will continue to […]
Siemens Healthineers and HeartFlow® Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs
Global agreement allows companies to develop integrated, noninvasive care solutions for improved management of coronary artery disease patients; the collaboration’s joint solution pairs CT scanners from Siemens Healthineers with the HeartFlow FFRCT Analysis ERLANGEN, Germany and REDWOOD CITY, Calif. USA – March 16, 2017 – Siemens Healthineers and HeartFlow, Inc. have entered into a global collaboration agreement to provide a […]
NICE Guidance Recommends HeartFlow FFRCT Analysis to Help Determine Cause of Stable Chest Pain in Patients
REDWOOD CITY, Calif. – Feb. 13, 2017 – The National Institute for Health and Care Excellence (NICE) in the United Kingdom issued guidance today for use of the HeartFlow® FFRCT Analysis to help determine the cause of stable chest pain in patients. Developed by HeartFlow, Inc., the HeartFlow FFRCT Analysis is the first non-invasive technology to provide insight into […]
HeartFlow FFRCT Analysis Receives Regulatory Approval in Japan
REDWOOD CITY, Calif. – Nov. 17, 2016 – HeartFlow Inc. has announced the approval of its HeartFlow® FFRCT Analysis by the Japanese Ministry of Health, Labour and Welfare (MHLW). The HeartFlow FFRCT Analysis is the only non-invasive technology to deliver insights on both the extent of a coronary blockage and any impact the blockage has on blood flow to the […]
Providence Health Care Becomes First Canadian Center to Adopt Revolutionary HeartFlow FFRCT Analysis to Assess Coronary Artery Disease
REDWOOD CITY, Calif. – July 21, 2016 – Providence Health Care has become the first center in Canada to adopt the HeartFlow® FFRCT Analysis, and also first in the world to utilize the next generation version of the platform. The HeartFlow FFRCT Analysis, which was recently approved by Health Canada, is a novel, non-invasive technology used by clinicians to assess […]
HeartFlow Introduces Next Generation Platform
REDWOOD CITY, Calif. – June 23, 2016 – HeartFlow, Inc., a personalized medical technology company seeking to transform the way cardiovascular disease is diagnosed and treated, announced today that it is launching its next generation of the HeartFlow® FFRCT Analysis. The result of years of development, the next generation platform includes major advancements in the process and algorithms […]
Technology from HeartFlow Provides Insights to Help Identify Coronary Plaques at Risk of Rupturing
Hemodynamic Assessment Could Improve Prediction of Acute Coronary Syndrome Risk PARIS – May 19, 2016 – First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow, Inc., may help predict which coronary plaques have the potential to rupture. The results were part of a study esigned to determine whether use of HeartFlow technology could […]
Highmark Health’s VITAL program partners with Allegheny Health Network and HeartFlow to evaluate a novel 3D technology
New modeling tool aids physicians’ ability to identify best treatment for patients with coronary artery disease Pittsburgh PA and Redwood City, CA (April 25, 2016) – Highmark Health, Allegheny Health Network (AHN), and HeartFlow, Inc. announced today that they are partnering to evaluate a novel non-invasive diagnostic technology that offers physicians insight into both the extent […]
One-Year PLATFORM Trial Results Reinforce Benefits of the HeartFlow FFRCT Analysis for Assessing Coronary Artery Disease
A HeartFlow FFRCT-Guided Strategy Helps Physicians Avoid Unnecessary Invasive Coronary Diagnostics CHICAGO, Ill. – April 4, 2016 – Novel technology developed by HeartFlow, Inc. significantly reduces the need for invasive procedures to diagnose patients suspected of having coronary artery disease. The HeartFlow® FFRCT Analysis also leads to a sustained reduction in the cost of care, according to one-year data […]
Trial Demonstrates HeartFlow FFRCT Analysis Significantly Lowers Cost of Care, Improves Quality of Life for Coronary Artery Disease
Up to 32% reduction in cost when using FFRCT-guided treatment strategy compared to invasive coronary angiography SAN FRANCISCO – Oct. 13, 2015 – New data shows that technology developed by HeartFlow, Inc. could lower the cost of evaluating patients with suspected coronary artery disease by as much as 32 percent. The late-breaking data, presented at the annual Transcatheter […]
